Your browser doesn't support javascript.
loading
A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma.
Cornell, Robert Frank; Baz, Rachid; Richter, Joshua R; Rossi, Adriana; Vogl, Dan T; Chen, Christine; Shustik, Chaim; Alvarez, Mariano J; Shen, Yao; Unger, T J; Ben-Shahar, Osnat; Wang, Hongwei; Baloglu, Erkan; Senapedis, William; Ma, Xiwen; Landesman, Yosef; Bai, Xiang; Bader, Justin; Xu, Hongmei; Marshall, Tracey; Chang, Hua; Walker, Christopher J; Shah, Jatin; Shacham, Sharon; Kauffman, Michael G; Hofmeister, Craig C.
Affiliation
  • Cornell RF; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.
  • Baz R; Moffitt Cancer Center, Tampa, Florida, USA.
  • Richter JR; Hackensack University John Theurer Cancer Center, Hackensack, New Jersey, USA.
  • Rossi A; Weill Cornell Medical College Myeloma Center, New York, New York, USA.
  • Vogl DT; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Chen C; UHN Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Shustik C; McGill University Health Centre, Montreal, Quebec, Canada.
  • Alvarez MJ; DarwinHealth Inc., New York, New York, USA.
  • Shen Y; DarwinHealth Inc., New York, New York, USA.
  • Unger TJ; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Ben-Shahar O; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Wang H; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Baloglu E; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Senapedis W; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Ma X; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Landesman Y; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Bai X; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Bader J; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Xu H; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Marshall T; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Chang H; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Walker CJ; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Shah J; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Shacham S; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Kauffman MG; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA.
  • Hofmeister CC; Ohio State University, Columbus, Ohio, USA.
Am J Hematol ; 97(2): E54-E58, 2022 02 01.
Article in En | MEDLINE | ID: mdl-34817872
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma / Neoplasm Recurrence, Local / Antineoplastic Agents Limits: Aged / Female / Humans / Male Language: En Journal: Am J Hematol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma / Neoplasm Recurrence, Local / Antineoplastic Agents Limits: Aged / Female / Humans / Male Language: En Journal: Am J Hematol Year: 2022 Document type: Article Affiliation country: Country of publication: